Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade
伊匹木单抗联合或不联合纳武利尤单抗治疗PD-1阻断后进展的经典霍奇金淋巴瘤患者
期刊:
影响因子:
doi:10.1016/j.bneo.2025.100173
Merryman, Reid W; Kline, Justin; Redd, Robert A; Olszewski, Harrison; Welsh, Emma; Pfaff, Kathleen; Lee, Hannah; McDonough, Mikaela; Ahn, Inhye E; Brown, Jennifer R; Crombie, Jennifer L; Davids, Matthew S; Fisher, David C; Jacobsen, Eric D; Jacobson, Caron A; Kim, Austin I; Odejide, Oreofe O; Parry, Erin Michelle; Ryan, Christine E; Shipp, Margaret A; Armand, Philippe; Rodig, Scott; Abramson, Jeremy S; LaCasce, Ann S